Additional European Equity News

AstraZeneca (AZN LN) - AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial. JPMorgan (JPM) analyst writes that "we see multi blockbuster potential", via Bloomberg. (AstraZeneca / Bloomberg)

Capita (CPI LN) - Secures GBP 107mln contract extension with Northern Ireland. (Newswires) 

Fluidra (FDR SM) - To invest in 27% of Aiper and form a strategic alliance, through a USD 100mln capital raise. (Newswires) 

Nordex (NDX1 GY) - Received orders from OX2 for 472 MW turbines. (Newswires) 

Travis Perkins (TPK LN) - FY (GBP): Adj. EPS 36.6p (prev. 54.4p Y/Y), Revenue 4.61bln (prev. 4.84bln Y/Y); notes that in 2025, trading conditions have continued to be challenging in the merchanting business but now stabilised, but volumes in a modest decline. (Newswires) 

Tesla (TSLA) / Autos - French new car registrations fell 14.54% Y/Y in March; Tesla sales have declined by 41.08% within the same time period. (Newswires) 

Mondi (MNDI LN) - Completed acquisition of Western Europe Packaging Assets of Schumacher Packaging. (Newswires) 

Vistry (VTY LN) - CEO buys 87,214 shares in co. at GBP 5.69/shr. (Newswires) 

Zurich Insurance Group (ZURN SW) - Zurich Insurance has agreed to acquire a significant minority stake in Icen Risk, a UK-based insurer specialising in M&A coverage. The deal, valued at approximately GBP 150mln, aims to support Icen's expansion into North America and major European markets, including Germany.

Allianz (ALV GY) resumed with Neutral at JPMorgan

Adidas (ADS GY) reiterated with Buy at Stifel 

Deliveroo (ROO LN) initiated with Overweight at Cantor 

Sainsbury's (SBRY LN) downgraded to Neutral from Outperform at BNP Paribas 

01 Apr 2025 - 07:05- EquitiesEU Research- Source: Newsquawk